Circadian Disruption, Fatigue, and Anorexia Clustering in Advanced Cancer Patients: Implications for Innovative Therapeutic Approaches

A disruption of the circadian timing system, as identified by monitoring of marker biorhythms, is common in cancer patients. The recording of the rest—activity rhythm with a wrist actigraph has been commonly used. This noninvasive monitoring allows a robust estimation of circadian disruption. The authors have previously found that altered patterns of circadian rest—activity rhythms are significantly and independently associated with the severity of fatigue and anorexia in patients with metastatic colorectal cancer. Elevated proinflammatory cytokines could partly account for this circadian disruption and its associated constitutional symptoms. Here, the authors present and discuss the data supporting the hypothesis that circadian disruption is often associated with fatigue and anorexia, which in turn further alter and dampen circadian synchronization, thus, creating a vicious cycle. This body of evidence paves the path for innovative therapeutic approaches targeting the circadian timing system in an effort to diminish constitutional symptoms induced by cancer and some anticancer treatments.

[1]  J. Bower Behavioral symptoms in patients with breast cancer and survivors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Jamie S Myers,et al.  Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. , 2008, Oncology nursing forum.

[3]  A. Berger,et al.  Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. , 2000, Oncology nursing forum.

[4]  Ueli Schibler,et al.  Circadian rhythms: mechanisms and therapeutic implications. , 2007, Annual review of pharmacology and toxicology.

[5]  David Spiegel,et al.  Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? , 2003, Brain, Behavior, and Immunity.

[6]  P. Stone,et al.  Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. , 2006, Journal of pain and symptom management.

[7]  N. Macdonald Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. , 2007, The journal of supportive oncology.

[8]  P. Andrews,et al.  Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment , 2002, Supportive Care in Cancer.

[9]  E. Voest,et al.  Symptom prevalence in patients with incurable cancer: a systematic review. , 2007, Journal of pain and symptom management.

[10]  Greg Atkinson,et al.  Jet lag: trends and coping strategies , 2007, The Lancet.

[11]  M. Mormont,et al.  Contribution of the rest–activity circadian rhythm to quality of life in cancer patients , 2002, Chronobiology international.

[12]  Erin L. McDearmon,et al.  The genetics of mammalian circadian order and disorder: implications for physiology and disease , 2008, Nature Reviews Genetics.

[13]  A. Chesson,et al.  Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. , 2007, Sleep.

[14]  U. Schibler Circadian time keeping: the daily ups and downs of genes, cells, and organisms. , 2006, Progress in brain research.

[15]  P. Stone,et al.  A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome , 2009, European journal of cancer.

[16]  T Roenneberg,et al.  Entrainment of the human circadian clock. , 2007, Cold Spring Harbor symposia on quantitative biology.

[17]  E. Bruera,et al.  Molecular epidemiology, cancer-related symptoms, and cytokines pathway. , 2008, The Lancet. Oncology.

[18]  A. Adamantidis,et al.  Sleep and metabolism: shared circuits, new connections , 2008, Trends in Endocrinology & Metabolism.

[19]  R. Cunningham,et al.  Putting evidence into practice: evidence-based interventions to prevent and manage anorexia. , 2009, Clinical journal of oncology nursing.

[20]  M. Hotopf,et al.  A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. , 2008, Journal of the National Cancer Institute.

[21]  Kathryn A. Lee,et al.  Impaired sleep and rhythms in persons with cancer. , 2004, Sleep medicine reviews.

[22]  R. Foster,et al.  The rhythm of rest and excess , 2005, Nature Reviews Neuroscience.

[23]  E. Maywood,et al.  Entrainment of the circadian system of mammals by nonphotic cues. , 1998, Chronobiology international.

[24]  F. Lévi,et al.  Circadian‐system alterations during cancer processes: A review , 1997, International journal of cancer.

[25]  D. Skene,et al.  Social influences on mammalian circadian rhythms: animal and human studies , 2004, Biological reviews of the Cambridge Philosophical Society.

[26]  H. Kraemer,et al.  Diurnal cortisol rhythm as a predictor of breast cancer survival. , 2000, Journal of the National Cancer Institute.

[27]  Declan Walsh,et al.  Symptom clustering in advanced cancer , 2006, Supportive Care in Cancer.

[28]  Takeshi Sakurai,et al.  The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness , 2007, Nature Reviews Neuroscience.

[29]  J Lellouch,et al.  Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  H. Geinitz,et al.  Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. , 2001, International journal of radiation oncology, biology, physics.

[31]  Loki Natarajan,et al.  Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. , 2009, Sleep.

[32]  J. Bower,et al.  Cancer-related fatigue: Links with inflammation in cancer patients and survivors , 2007, Brain, Behavior, and Immunity.

[33]  Clete Kushida,et al.  Practice parameters for using polysomnography to evaluate insomnia: an update. , 2003, Sleep.

[34]  A. B. Reddy,et al.  A clockwork web: circadian timing in brain and periphery, in health and disease , 2003, Nature Reviews Neuroscience.

[35]  M. Dodd,et al.  Symptom clusters: the new frontier in symptom management research. , 2004, Journal of the National Cancer Institute. Monographs.

[36]  M. Hertzog,et al.  Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy , 2009, Supportive Care in Cancer.

[37]  M. Ramoni,et al.  Links between regimen-related toxicities in patients being treated for colorectal cancer , 2009, Current opinion in supportive and palliative care.

[38]  Kathryn A. Lee,et al.  Methodological challenges when using actigraphy in research. , 2008, Journal of pain and symptom management.

[39]  S. Ancoli-Israel,et al.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  E. Bruera,et al.  Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. , 2004, Cytokine.

[41]  A. Reinberg,et al.  Euchronism, Allochronism, and Dyschronism: Is Internal Desynchronization of Human Circadian Rhythms a Sign of Illness? , 2007, Chronobiology international.

[42]  S. Asch,et al.  Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  P. Ganz,et al.  Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer , 2009, Clinical Cancer Research.

[44]  C. Drake,et al.  Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. , 2004, Sleep.

[45]  A. Berger,et al.  Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. , 1998, Oncology nursing forum.

[46]  Circadian function in patients with advanced non-small-cell lung cancer , 2005, British Journal of Cancer.

[47]  Christine Miaskowski,et al.  Occurrence of symptom clusters. , 2004, Journal of the National Cancer Institute. Monographs.

[48]  A. Berger,et al.  The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. , 1999, Oncology nursing forum.

[49]  John O'Neill,et al.  Circadian timing in health and disease. , 2006, Progress in brain research.

[50]  Sonia Ancoli-Israel,et al.  Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer , 2006, Supportive Care in Cancer.

[51]  G. Richardson,et al.  Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies. , 2000, Sleep.

[52]  C. McClung,et al.  Circadian genes, rhythms and the biology of mood disorders. , 2007, Pharmacology & therapeutics.

[53]  C. Pollak,et al.  The role of actigraphy in the study of sleep and circadian rhythms. , 2003, Sleep.

[54]  R. Dantzer,et al.  A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms , 2004, Neuroimmunomodulation.

[55]  Steven A. Brown,et al.  The mammalian circadian timing system: from gene expression to physiology , 2004, Chromosoma.

[56]  Kathryn A. Lee,et al.  Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. , 1999, Journal of pain and symptom management.

[57]  G. Morrow Cancer-related fatigue: causes, consequences, and management. , 2007, The oncologist.

[58]  Elizabeth B. Klerman,et al.  Clinical Aspects of Human Circadian Rhythms , 2005, Journal of biological rhythms.

[59]  N. Tinari,et al.  Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  C. Miaskowski Symptom clusters: establishing the link between clinical practice and symptom management research , 2006, Supportive Care in Cancer.

[61]  Steven A. Brown,et al.  Peripheral Circadian Oscillators in Mammals: Time and Food , 2003, Journal of biological rhythms.

[62]  M. Chiu,et al.  Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.

[63]  D. Spiegel Losing sleep over cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  F. Davis,et al.  Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters , 2005, Brain Research.

[65]  S. Ancoli-Israel,et al.  The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer , 2005, Biological Psychology.

[66]  M. Perlis,et al.  Cancer-related fatigue and sleep disorders. , 2007, The oncologist.

[67]  C A Czeisler,et al.  Circadian timekeeping in health and disease. Part 1. Basic properties of circadian pacemakers. , 1983, The New England journal of medicine.

[68]  Stefano Iacobelli,et al.  Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer , 2005, Clinical Cancer Research.

[69]  D. Skene,et al.  Nonphotic Entrainment in Humans? , 2005, Journal of biological rhythms.

[70]  C A Czeisler,et al.  Circadian timekeeping in health and disease. Part 2. Clinical implications of circadian rhythmicity. , 1983, The New England journal of medicine.

[71]  P. Zee,et al.  Current understanding of the circadian clock and the clinical implications for neurological disorders. , 2001, Archives of neurology.

[72]  M. Dodd,et al.  Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. , 2007, Journal of the National Cancer Institute. Monographs.

[73]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[74]  Max Hirshkowitz,et al.  Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. , 2003, Sleep.

[75]  Sangeeta Agrawal,et al.  Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. , 2007, Journal of pain and symptom management.

[76]  T. Rich Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. , 2007, The journal of supportive oncology.

[77]  T. Sakurai Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. , 2006, CNS & neurological disorders drug targets.

[78]  J. Sprouse Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics , 2004, Expert opinion on therapeutic targets.

[79]  Mellar P. Davis,et al.  Systematic review of the treatment of cancer-associated anorexia and weight loss. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  Anna Wirz-Justice,et al.  Biological rhythm disturbances in mood disorders , 2006, International clinical psychopharmacology.

[81]  F. Davis,et al.  Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters , 2009, Behavioural Brain Research.

[82]  S. Ancoli-Israel,et al.  The Effects of Standard Anthracycline-Based Chemotherapy on Soluble ICAM-1 and Vascular Endothelial Growth Factor Levels in Breast Cancer , 2004, Clinical Cancer Research.

[83]  L. Nail,et al.  Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. , 2006, Oncology nursing forum.

[84]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[85]  V. Perry,et al.  Identification and treatment of symptoms associated with inflammation in medically ill patients , 2008, Psychoneuroendocrinology.

[86]  F. Lévi,et al.  Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status , 2002, Chronobiology international.

[87]  S. Reppert,et al.  Coordination of circadian timing in mammals , 2002, Nature.

[88]  R. Dantzer,et al.  Cytokine-induced sickness behavior , 2003, Brain, Behavior, and Immunity.

[89]  R. Dantzer,et al.  Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? , 2003, Cancer.

[90]  I. Bosaeus,et al.  Daily Physical-Rest Activities in Relation to Nutritional State, Metabolism, and Quality of Life in Cancer Patients with Progressive Cachexia , 2007, Clinical Cancer Research.

[91]  M. Ramoni,et al.  Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy , 2008, Cancer.

[92]  N. Douglas,et al.  Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  F. Lévi,et al.  Non‐invasive estimation of the circadian rhythm in serum cortisol in patients with ovarian or colorectal cancer , 1998, International journal of cancer.

[94]  S. Ancoli-Israel,et al.  Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer , 2008, Brain, Behavior, and Immunity.

[95]  L. Tulman,et al.  Symptom Clusters: Concept Analysis and Clinical Implications for Cancer Nursing , 2005, Cancer nursing.

[96]  F. Lévi,et al.  Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. , 2007, Cold Spring Harbor symposia on quantitative biology.

[97]  Andrew N. Coogan,et al.  Neuroimmunology of the circadian clock , 2008, Brain Research.

[98]  I. Tannock,et al.  Cytokines and their relationship to the symptoms and outcome of cancer , 2008, Nature Reviews Cancer.

[99]  S. Iacobelli,et al.  Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. , 2009, Cancer research.

[100]  S. Kay,et al.  Mammalian circadian signaling networks and therapeutic targets. , 2007, Nature chemical biology.

[101]  L. Sarna,et al.  Physical activity and fatigue during radiation therapy: a pilot study using actigraph monitors. , 2001, Oncology nursing forum.

[102]  P. Jean-Pierre,et al.  Cancer-related fatigue: the scale of the problem. , 2007, The oncologist.

[103]  C. Weitz,et al.  Regulation of Daily Locomotor Activity and Sleep by Hypothalamic EGF Receptor Signaling , 2001, Science.